Dr. Tao Chen | Cardiovascular Mortality | Best Researcher Award
Fujian Medical University | China
Tao Chen is a distinguished medical professional and researcher in the field of endocrinology and metabolism, currently serving as an Associate Chief Physician at the Affiliated Longyan First Hospital of Fujian Medical University and as a postgraduate tutor at Fujian Medical University. With extensive clinical and academic experience, he has played a vital role in medical education, scientific research, and the advancement of endocrine medicine. His primary research interests encompass diabetes, insulin resistance, metabolic disorders, osteoporosis, and the role of vitamin D in neuropathy. Tao Chen has published five scholarly papers focusing on topics such as glucose regulation, serum irisin levels and their relationship with insulin sensitivity, the effects of exercise on metabolic indicators, and vitamin D3-related complications in type 2 diabetes. His publications have collectively received 25 citations across 5 documents, and he holds an h-index of 3, reflecting his consistent contribution to clinical and academic research. Beyond research, he is actively involved in multiple professional organizations, serving as a council and committee member in various endocrinology and diabetes societies. He is also the Vice Chairman of the Osteoporosis and Bone Mineral Salt Disease Branch of the Longyan Medical Association and serves as a food and drug safety expert for the Longyan Municipal People’s Government. Through his ongoing leadership, research, and mentorship, Tao Chen continues to make meaningful contributions to endocrinology and medical science.
Featured Publications
Lai, X., & Chen, T. (2024). Association of serum uric acid to high-density lipoprotein cholesterol ratio with all-cause and cardiovascular mortality in patients with diabetes or prediabetes: A prospective cohort study. Frontiers in Endocrinology.
Lai, X., & Chen, T. (2024). Association between the triglyceride–glucose index and serum soluble Klotho in middle-aged and older adults from NHANES 2007–2016. Scientific Reports.
Chen, T., Xing, X., Huang, L., Tu, M., Lai, X., Wen, S., Cai, J., Lin, S., Zheng, Y., Lin, Y., et al. (2023). Efficacy and safety of high-dose intramuscular vitamin D₂ injection in type 2 diabetes mellitus with distal symmetric polyneuropathy combined with vitamin D insufficiency: Study protocol for a multicenter, randomized, double-blinded, and placebo-controlled trial. Frontiers in Endocrinology.
Chen, T. (2022). Type 2 diabetes mellitus complicated with atherosclerotic cardiovascular disease patient treated with semaglutide: A case report. Chinese Journal of Diabetes.